Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aminoacidopathies
aminoacidurias
amyloidosis
autonomic dysfunction
Bence Jones protein
bone marrow biopsy
bone survey
bone survey, metastatic
CAT scan
CAT scan, abnormal
CAT scan, base of skull
CAT scan, contrast enhanced
cerebrospinal fluid, gammaglobulin of
Clinical Pathologic Conference(C.P.C.)
cranial nerve palsies
cranial neuropathy
cranial neuropathy, multiple
cystinuria
diplopia
electrophoretic pattern, serum
electrophoretic pattern, urine
facial nerve palsy
facial pain
immunoelectrophoresis, serum
Lhermitte's sign
medial rectus palsy
monoclonal gammopathy
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, skull bone changes
multiple myeloma
multiple sclerosis, differential diagnosis of
myeloma, osteosclerotic
nerve biopsy
neuropathy
neuropathy, peripheral
paraparesis, spastic
plasma cell myeloma, CNS involvement associated with
plasmacytoma
pleocytosis of cerebrospinal fluid
prognosis
proteinuria
renal stones
seizure
third nerve palsy
urinary incontinence
visual acuity, decreased
visual acuity, decreased, monocular
visual loss, slow-unilateral
Showing articles 900 to 950 of 1480 << Previous Next >>

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999

Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999

Sensory Symptoms Restricted to Proximal Body Parts in Small Cortical Infarction
Neurol 53:889-890, Kim,J.S., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

Distal Myasthenic Gravis
Neurol 52:632-634, Nations,S.P.,et al, 1999

"Toilet Seat" Sciatic Neuropathy
Arch Neurol 56:116, Holland,N.R.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999

Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999

Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999

Intracerebral Hemorrhage in Young People,Analysis of Risk Factors,Location,Causes,and Prognosis
Stroke 30:537-541, Rutz-Sandoval,J.L.,et al, 1999

Posterior Cerebral Artery Territory Infarcts in the New England Medical Center Posterior Circulation Registry
Arch Neurol 56:824-832, Yamamoto,Y.,et al, 1999

Pain and the Guillain-Barre Syndrome in Children Under 6 Years
J Pediatr 134:773-776, Nguyen,D.K.,et al, 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

Transient MRI Enhancement in a Patient with Seizures and Previously Resected Glioma:Use of MRS
Neurol 53:211-213, Quan,D.,et al, 1999

Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999

Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999

Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999

The Wide Spectrum of Myofibrillar Myopathy Suggests a Multifactorial Etiology and Pathogenesis
Neurol 51:1646-1655, Amato,A.A.,et al, 1998

Lateral Medullary Infarction
Stroke, Pathophysiology, Diagnosis and management, Churchhill Livingstone, NY 3rd Ed, Ch 22, p. 534, Amarenco,P.,et al, 1998

Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998

The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998

The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
NEJM 339:1797-1802,1845, Lasky,T.,et al, 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Mild Traumatic Brain Injury,Toward Understanding Manifestations and Treatment
Arch Int Med 158:90-97, Kushner,D., 1998

Alcohol-Related Acute Axonal Polyneuropathy,A Differential Diagnosis of Guillain-Barre Syndrome
Arch Neurol 55:1329-1334, Wohrle,J.C.,et al, 1998

Ataxic Hemiparesis,Critical Appraisal of a Lacunar Syndrome
Stroke 29:2549-2555, Gorman,M. J.,et al, 1998

Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998

Acute Inflammatory Demyelinating Polyradiculopathy in Children:Clinical and Electrodiagnostic Studies
Ann Neurol 44:350-356, Delanoe,C.,et al, 1998

Minimal Number of Plasma Exchanges Needed to Reduce Immunoglobulin in Guillain-Barre Syndrome
Neurol 51:875-877, Yuki,N.,et al, 1998

Myasthenic Hand
Neurol 51:913-914, Janssen,J.C.,et al, 1998

Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998

Guillain-Barre Syndrome:MR Imaging Findings of the Spine in Eight Patients
Radiology 208:137-141, Byun,W.M.,et al, 1998

Recurrent Primary Cerebral Hemorrhage, Frequency, Mechanisms, and Prognosis
Stroke 29:1802-1805, Gonzalez-Duarte,A.,et al, 1998

Intracerebral Haemorrhage Caused by Drug Abuse
Lancet 351:1029, McEvoy,A.W.,et al, 1998

Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998

Effects of Copolymer-1 on Serial Gadolinium-Enhanced MRI in Relapsing Remitting Multiple Sclerosis
Neurol 50:1127-1133, Mancardi,G.L.,et al, 1998

Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis
Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998

Use of Corticosteroids in Multiple Sclerosis by Consultant Neurologists in the United Kingdom
JNNP 54:362-365, Tremlett,H.L.,et al, 1998

Arterial Territories of the Human Brain, Cerebral Hemispheres
Neurol 50:1699-1708, Tatu,L.,et al, 1998

Distal Hereditary Upper Limb Muscular Atrophy
JNNP 64:217-220, Gross,D.W.,et al, 1998



Showing articles 900 to 950 of 1480 << Previous Next >>